The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Nanocarrier-based topical drug delivery for the treatment of skin diseases
Abstract
INTRODUCTION: Skin disorders will continue to cause complications in patients. At present, there is an expansion of research into dermatologic treatment due to a critical need for new treatment options to treat skin diseases. AREAS COVERED: The skin itself provides a natural barrier against particle penetration for topical delivery. However, it also offers a potential approach for the delivery of therapeutics, especially in diseased skin and via the openings of hair follicles. Recent innovation might be achieved in the field of dermatological treatment with improvement in the dermal localization of bioactives into the affected skin region, via novel nanocarriers that deliver the drugs directly to the target cells. After application, these nanocarriers can penetrate through the stratum corneum into viable skin and accumulate at the target site. However, noteworthy uptake does occur after damage and in certain diseased skin. EXPERT OPINION: Skin-targeted topical delivery by means of nanosystems, in order to produce sustained release and maintain a localized effect, will result in an effective treatment of various life-threatening dermatological conditions. In addition, research continues into the interactions between novel particles, skin and skin lipid, and the influence of particle composition on drug distribution within the skin strata.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gupta, M., Tiwari, S., & Vyas, S. P. (2011) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2011.598161 · Cited by 39
Self-citationRetractedSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products
Pardeike, J., Hommoss, A., & Müller, R. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.003 · Cited by 1,478
Touitou, E., Dayan, N., Bergelson, L., Godin, B., & Eliaz, M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00222-9 · Cited by 1,345
Novel mechanisms and devices to enable successful transdermal drug delivery
Barry, B. W. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00167-1 · Cited by 1,240
Development of Nanoparticles for Antimicrobial Drug Delivery
Zhang, L., Pornpattananangkul, D., Hu, C.-M., & Huang, C.-M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790416290 · Cited by 886
Nanoparticles and microparticles for skin drug delivery
Prow, T. W., Grice, J. E., Lin, L. L., Faye, R., Butler, M., Becker, W., Wurm, E. M. T., Yoong, C., Robertson, T. A., Soyer, H. P., et al. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.01.012 · Cited by 873
Particle size of liposomes influences dermal delivery of substances into skin
Verma, D. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00183-2 · Cited by 702
Lipid vesicles and other colloids as drug carriers on the skin
Cevc, G. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.028 · Cited by 700
Souto, E. B., Wissing, S. A., Barbosa, C. M., & Müller, R. H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.02.032 · Cited by 692
Dermatological formulations: Percutaneous absorption
(1984) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(84)90021-1 · Cited by 589
Nanoparticles – An efficient carrier for drug delivery into the hair follicles
Lademann, J., Richter, H., Teichmann, A., Otberg, N., Blume-Peytavi, U., Luengo, J., Weiß, B., Schaefer, U. F., Lehr, C.-M., & Wepf, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.10.019 · Cited by 573
Skin barrier : principles of percutaneous absorption
Schaefer, H. E., & Redelmeier, T. E. (1996) · Cited by 565
Lipid vesicles for skin delivery of drugs: Reviewing three decades of research
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., & Khalafallah, N. M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.005 · Cited by 537
Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery
Schreier, H., & Bouwstra, J. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90039-6 · Cited by 532
Fang, J.-Y., Fang, C.-L., Liu, C.-H., & Su, Y.-H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.008 · Cited by 518
Cevc, G. (1996) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v13.i3-4.30 · Cited by 506
Mezei, M., & Gulasekharam, V. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90268-4 · Cited by 501
El Zaafarany, G. M., Awad, G. A. S., Holayel, S. M., & Mortada, N. D. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.034 · Cited by 485
Cevc, G., & Blume, G. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00369-8 · Cited by 406
Mitri, K., Shegokar, R., Gohla, S., Anselmi, C., & Müller, R. H. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.008 · Cited by 404
Vogt, A., Combadiere, B., Hadam, S., Stieler, K. M., Lademann, J., Schaefer, H., Autran, B., Sterry, W., & Blume-Peytavi, U. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700226 · Cited by 398
Song, C. K., Balakrishnan, P., Shim, C.-K., Chung, S.-J., Chong, S., & Kim, D.-D. (2012) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.12.004 · Cited by 380
Vesicles as a tool for transdermal and dermal delivery
Honeywell-Nguyen, P. L., & Bouwstra, J. A. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.003 · Cited by 365
Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery
SHAH, K., DATE, A., JOSHI, M., & PATRAVALE, V (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.061 · Cited by 359
Dermal Absorption and Toxicity Assessment
(2007) · CRC Press eBooks · doi:10.3109/9780849375927 · Cited by 340
Paolino, D., Lucania, G., Mardente, D., Alhaique, F., & Fresta, M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.007 · Cited by 339
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Sinico, C., Manconi, M., Peppi, M., Lai, F., Valenti, D., & Fadda, A. M. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.020 · Cited by 325
Nanostructured lipid carrier (NLC) based gel of celecoxib
Joshi, M., & Patravale, V. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.060 · Cited by 302
Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles
Cheow, W. S., & Hadinoto, K. (2011) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2011.02.033 · Cited by 297
Skin structure and mode of action of vesicles
Bouwstra, J. A., & Honeywell-Nguyen, P. L. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00114-x · Cited by 293
Deformable liposomes for dermal administration of methotrexate
Trotta, M., Peira, E., Carlotti, M. E., & Gallarate, M. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.10.006 · Cited by 285
Preparation and characteristics of monostearin nanostructured lipid carriers
Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., & Zeng, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.040 · Cited by 269
Verma, P., & Pathak, K. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.07.004 · Cited by 265
Interaction of liposomes with human skin in vitro — The influence of lipid composition and structure
Kirjavainen, M., Urtti, A., Jääskeläinen, I., Marjukka Suhonen, T., Paronen, P., Valjakka-Koskela, R., Kiesvaara, J., & Mönkkönen, J. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00126-9 · Cited by 252
Enhancement of Topical Delivery from Biodegradable Nanoparticles
Alvarez-Rom#x00E1;n, R., Naik, A., Kalia, Y. N., Guy, R. H., & Fessi, H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045235.86197.ef · Cited by 248
Can drug-bearing liposomes penetrate intact skin?
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.4.0001 · Cited by 231
Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs
Shah, P. P., Desai, P. R., Patel, A. R., & Singh, M. S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.011 · Cited by 229
Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC
Teeranachaideekul, V., Boonme, P., Souto, E. B., Müller, R. H., & Junyaprasert, V. B. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.011 · Cited by 215
Elastic liposomes for skin delivery of dipotassium glycyrrhizinate
Trotta, M., Peira, E., Debernardi, F., & Gallarate, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00266-1 · Cited by 212
Development of SLNs from natural lipids: Application to topical delivery of tretinoin
Mandawgade, S. D., & Patravale, V. B. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.028 · Cited by 211
Langbein, L., Grund, C., Kuhn, C., Praetzel, S., Kartenbeck, J., Brandner, J. M., Moll, I., & Franke, W. W. (2002) · European Journal of Cell Biology · doi:10.1078/0171-9335-00270 · Cited by 210
SLN and NLC for topical delivery of ketoconazole
Souto, E. B., & Müller, R. H. (2005) · Journal of Microencapsulation · doi:10.1080/02652040500162436 · Cited by 208
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro
El Maghraby, G. M. M., Williams, A. C., & Barry, B. W. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776450 · Cited by 204
Investigations on the occlusive properties of solid lipid nanoparticles (SLN).
Wissing, S. A., Lippacher, A., & Müller, R. (2001) · PubMed · Cited by 199
Advances in transcutaneous vaccine delivery: Do all ways lead to Rome?
Bal, S. M., Ding, Z., van Riet, E., Jiskoot, W., & Bouwstra, J. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.018 · Cited by 199
Batheja, P., Sheihet, L., Kohn, J., Singer, A. J., & Michniak-Kohn, B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.005 · Cited by 197
Dermal drug delivery by liposome encapsulation: Clinical and electron microscopic studies
Foldvari, M., Gesztes, A., & Mezei, M. (1990) · Journal of Microencapsulation · doi:10.3109/02652049009040470 · Cited by 190
Drug Targeting by Solid Lipid Nanoparticles for Dermal Use
Santos Maia, C., Mehnert, W., Schaller, M., Korting, H. C., Gysler, A., Haberland, A., & Schäfer-korting, M. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000038364 · Cited by 186
Bioavailability and bioequivalence of topical glucocorticoids
Wiedersberg, S., Leopold, C. S., & Guy, R. H. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.007 · Cited by 169
Abdel-Mottaleb, M. M. A., Neumann, D., & Lamprecht, A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.04.009 · Cited by 167
Gupta, M., & Vyas, S. P. (2012) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2012.01.006 · Cited by 160
Self-citationLecithin/chitosan nanoparticles of clobetasol-17-propionate capable of accumulation in pig skin
Şenyiğit, T., Sonvico, F., Barbieri, S., Özer, Ö., Santi, P., & Colombo, P. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.11.013 · Cited by 157
Cirri, M., Bragagni, M., Mennini, N., & Mura, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.07.015 · Cited by 155
Influence of Nanoencapsulation on Human Skin Transport of Flufenamic Acid
Luengo, J., Weiss, B., Schneider, M., Ehlers, A., Stracke, F., König, K., Kostka, K., Lehr, C., & Schaefer, U. F. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000093114 · Cited by 152
Manconi, M., Caddeo, C., Sinico, C., Valenti, D., Mostallino, M. C., Biggio, G., & Fadda, A. M. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.010 · Cited by 149
Piemi, M. P. Y., Korner, D., Benita, S., & Marty, J.-P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00156-4 · Cited by 149
Enhancement of follicular delivery of finasteride by liposomes and niosomes
Tabbakhian, M., Tavakoli, N., Jaafari, M. R., & Daneshamouz, S. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.05.041 · Cited by 146
Penetration enhancer containing vesicles as carriers for dermal delivery of tretinoin
Manconi, M., Sinico, C., Caddeo, C., Vila, A. O., Valenti, D., & Fadda, A. M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.03.068 · Cited by 145
Novel micelle formulations to increase cutaneous bioavailability of azole antifungals
Bachhav, Y. G., Mondon, K., Kalia, Y. N., Gurny, R., & Möller, M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.03.003 · Cited by 143
Hofland, H. E. J., Bouwstra, J. A., Boddé, H. E., Spies, F., & Junginger, H. E. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb16940.x · Cited by 142
Sivaramakrishnan, R., Nakamura, C., Mehnert, W., Korting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.001 · Cited by 141
Štecová, J., Mehnert, W., Blaschke, T., Kleuser, B., Sivaramakrishnan, R., Zouboulis, C. C., Seltmann, H., Körting, H. C., Kramer, K. D., & Schäfer‐Korting, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9225-9 · Cited by 140
Ourique, A. F., Melero, A., Silva, C. D. B. D., Schaefer, U. F., Pohlmann, A. R., Guterres, S. S., Lehr, C.-M., Kostka, K.-H., & Beck, R. C. R. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.03.008 · Cited by 132
Başpınar, Y., & Borchert, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.040 · Cited by 132
In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin
Jensen, L. B., Petersson, K., & Nielsen, H. M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.05.012 · Cited by 128
Körting, H. C., Zienicke, H., Sch�fer-Korting, M., & Braun‐Falco, O. (1990) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315408 · Cited by 123
Castro, G. A., Coelho, A. L. L. R., Oliveira, C. A., Mahecha, G. A. B., Oréfice, R. L., & Ferreira, L. A. M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.025 · Cited by 119 · cited 1×
“They have also become available and opened up both opportunities/ options for therapeutic strategies to treat skin diseases [24,25].”
BackgroundPople, P. V., & Singh, K. K. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.02.016 · Cited by 119
Pople, P. V., & Singh, K. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.008 · Cited by 117
Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen
Elsayed, M. M. A., Abdallah, O. Y., Naggar, V. F., et al. (2007) · Die Pharmazie · doi:10.31083/ph.2007.2.6082 · Cited by 115
Therapeutic progress with topical liposome drugs for skin disease
Schmid, M.-H., & Korting, H. C. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00019-4 · Cited by 113
Shunmugaperumal, T., Venkateshan, N., & Ludwig, A. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.006 · Cited by 111
Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers
Garg, A., & Singh, S. K. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.05.030 · Cited by 102
Geusens, B., Gele, M. V., Braat, S., Smedt, S. C. D., Stuart, M. C. A., Prow, T. W., Sanchez, W. Y., Roberts, M. S., Sanders, N. N., & Lambert, J. (2010) · Advanced Functional Materials · doi:10.1002/adfm.201000484 · Cited by 97
Gupta, M., Goyal, A. K., Paliwal, S. R., Paliwal, R., Mishra, N., Vaidya, B., Dube, D., Jain, S., & Vyas, S. P. (2010) · Journal of Liposome Research · doi:10.3109/08982101003596125 · Cited by 96
Self-citationShah, P. P., Desai, P. R., & Singh, M. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.016 · Cited by 90
Lecithin vesicles for topical delivery of diclofenac
Boinpally, R., Zhou, S., Poondru, S., Devraj, G., & Jasti, B. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00143-7 · Cited by 89
A Physiologically Based Pharmacokinetic Model of Organophosphate Dermal Absorption
van der Merwe, D., Brooks, J. D., Gehring, R., Baynes, R. E., Monteiro-Riviere, N. A., & Riviere, J. E. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfj014 · Cited by 83
Positively charged microemulsions for topical application
Peira, E., Carlotti, M. E., Trotta, C., Cavalli, R., & Trotta, M. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.05.065 · Cited by 82
The Potential of Liposomal Drug Delivery for the Treatment of Inflammatory Arthritis
Vanniasinghe, A. S., Bender, V., & Manolios, N. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.004 · Cited by 80
Solubility and in vitro transdermal diffusion of riboflavin assisted by PAMAM dendrimers
Filipowicz-Rachwał, A., & Wołowiec, S. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.033 · Cited by 78
Pham, H. H., Luo, P., Génin, F., & Dash, A. K. (2002) · AAPS PharmSciTech · doi:10.1208/pt030101 · Cited by 75
Hexosomes: A Novel Drug Delivery System
Hirlekar, R. S., Jain, S., Patel, M., Garse, H., & Kadam, V. (2010) · Current Drug Delivery · doi:10.2174/156720110790396526 · Cited by 72
Samah, N. H. A., Williams, N., & Heard, C. M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.08.011 · Cited by 68
Cleary, G. W. (1988) · Journal of Controlled Release · doi:10.1016/0168-3659(88)90065-x · Cited by 68
Ultradeformable archaeosomes as new topical adjuvants
Higa, L. H., Schilrreff, P., Perez, A. P., Iriarte, M. A., Roncaglia, D. I., Morilla, M. J., & Romero, E. L. (2012) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2012.02.008 · Cited by 62
Ortiz-Romero, P. L., Hansen, S. H., Shah, V., Menné, T., & Benfeldt, E. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0562 · Cited by 62
In vitro retinoic acid release and skin permeation from different liposome formulations
Montenegro, L., Panico, A. M., Ventimiglia, A., & Bonina, F. P. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(95)04422-1 · Cited by 60
Hrynyk, M., Martins‐Green, M. M., Barron, A. E., & Neufeld, R. J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.052 · Cited by 55
Enhancement of Topical Delivery of a Lipophilic Drug from Charged Multilamellar Liposomes
Katahira, N., Murakami, T., Kugai, S., Yata, N., & Takano, M. (1999) · Journal of drug targeting · doi:10.3109/10611869908996847 · Cited by 55
Retinoids: new use by innovative drug-delivery systems
Trapasso, E., Cosco, D., Celia, C., Fresta, M., & Paolino, D. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902832827 · Cited by 49
Microemulsion-based Hydrogel Formulation of Itraconazole for Topical Delivery
Lee, E., Balakrishnan, P., Song, C.-K., Choi, J., Noh, G.-Y., Park, C.-G., Choi, A.-J., Chung, S., Shim, C., & Kim, D. (2010) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2010.40.5.305 · Cited by 46
Infectious Skin Diseases: A Review and Needs Assessment
Dawson, A. L., Dellavalle, R. P., & Elston, D. M. (2011) · Dermatologic Clinics · doi:10.1016/j.det.2011.08.003 · Cited by 43
Interaction of liposomes with human skin: the role of the stratum corneum
Schaller, M., & Korting, H. C. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00076-j · Cited by 41
Preparation and evaluation of aceclofenac topical microemulsion.
Shah, R. R., Magdum, C. S., Patil, S. S., & Niakwade, N. S. (2010) · PubMed Central · Cited by 35
THE MAGNITUDE OF SKIN DISEASE IN THE UNITED STATES
Fleischer, A. B., Feldman, S. R., & Rapp, S. R. (2000) · Dermatologic Clinics · doi:10.1016/s0733-8635(05)70163-7 · Cited by 34
New Developments in Topical Antifungal Therapy
Robert, M. E. M., & Kalia, Y. N. (2006) · American Journal of Drug Delivery · doi:10.2165/00137696-200604040-00006 · Cited by 32
Liposomal Nanocarriers for Tumor Imaging
Erdoğan, S. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1016 · Cited by 32
Improving topical treatments for skin diseases
Sigmundsdóttir, H. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.03.004 · Cited by 27
Roberts, M. S. (2007) · CRC Press eBooks · doi:10.3109/9780849375927-16 · Cited by 12
Derivatization of Steroids for Obtaining Conjugates: Use as Vectors for Drug Delivery
Faruk, A., & Ishar, M. P. S. (2010) · Journal of Pharmaceutical Research · doi:10.18579/jpcrkc/2010/9/1/79469 · Cited by 12
Cited by
Microneedles: A smart approach and increasing potential for transdermal drug delivery system
Waghule, T., Singhvi, G., Dubey, S. K., Pandey, M. M., Gupta, G., Singh, M., & Dua, K. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.078 · Cited by 1,260
Metal-organic frameworks as potential drug delivery systems
Sun, C.-Y., Qin, C., Wang, X.-L., & Su, Z.-M. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.741583 · Cited by 408
Palmer, B., & DeLouise, L. (2016) · Molecules · doi:10.3390/molecules21121719 · Cited by 267
Topical drug delivery systems: a patent review
Singh Malik, D., Mital, N., & Kaur, G. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1131267 · Cited by 192
“50–150-μm-thick outer epidermis (biological barrier), 250-μm-thick dermis (thermal barrier) and innermost subcutaneous fatty tissue (mechanical cushion).[30]”
BackgroundIn Vitro and Ex Vivo Models for Screening Topical Anti-Inflammatory Drugs
Pérez-Salas, J. L., Moreno-Jiménez, M. R., Rocha-Guzmán, N. E., González-Laredo, R. F., Medina-Torres, L., & Gallegos-Infante, J. A. (2023) · Scientia Pharmaceutica · doi:10.3390/scipharm91020020 · Cited by 22
“It consists of three regions (Figure 1): a 50–150 μm thick outer epidermis (biological barrier), a 250 μm thick dermis (thermal barrier), and the innermost subcutaneous adipose tissue (mechanical cushion) [9].”
Background
Metadata
- Authors
- Gupta, M., Agrawal, U., & Vyas, S. P.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2012-05-05
- Volume
- 9
- Issue
- 7
- Pages
- 783-804
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2100389865
- Cited by
- 278
- References
- 104
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.